These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2600190)

  • 21. Renal function and tubular transport effects of sulindac and naproxen in chronic heart failure.
    Eriksson LO; Beermann B; Kallner M
    Clin Pharmacol Ther; 1987 Dec; 42(6):646-54. PubMed ID: 3319349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased synthesis of systemic prostacyclin in cirrhotic patients.
    Guarner F; Guarner C; Prieto J; Colina I; Quiroga J; Casas J; Freixa R; Rosello J; Gelpi E; Balanzo J
    Gastroenterology; 1986 Mar; 90(3):687-94. PubMed ID: 3510938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sulindac does not spare renal prostaglandins.
    Waslen TA; McCauley FA; Wilson TW
    Clin Invest Med; 1989 Apr; 12(2):77-81. PubMed ID: 2650941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of suppression of prostaglandin synthesis on renal function in rats with intact and reduced renal mass.
    Rubinger D; Frishberg Y; Eldor A; Popovtzer MM
    Prostaglandins; 1985 Oct; 30(4):651-68. PubMed ID: 4081063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of ibuprofen, naproxen, and sulindac on prostaglandins in men.
    Brater DC; Anderson S; Baird B; Campbell WB
    Kidney Int; 1985 Jan; 27(1):66-73. PubMed ID: 3884880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of nonsteroidal anti-inflammatory drugs in healthy subjects.
    Sedor JR; Davidson EW; Dunn MJ
    Am J Med; 1986 Aug; 81(2B):58-70. PubMed ID: 3092666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of sulindac and ibuprofen in patients with cirrhosis and ascites. An explanation for the renal-sparing effect of sulindac.
    Laffi G; Daskalopoulos G; Kronborg I; Hsueh W; Gentilini P; Zipser RD
    Gastroenterology; 1986 Jan; 90(1):182-7. PubMed ID: 3079594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The renal excretion of prostaglandins and changes in plasma renin during treatment with either sulindac or naproxen in patients with rheumatoid arthritis and thiazide treated heart failure.
    Svendsen UG; Gerstoft J; Hansen TM; Christensen P; Lorenzen I
    J Rheumatol; 1984 Dec; 11(6):779-82. PubMed ID: 6394759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double blind comparison of naproxen and sulindac in female patients with heart failure.
    Beermann B; Eriksson LO; Kallner M
    Scand J Rheumatol Suppl; 1986; 62():32-5. PubMed ID: 3541166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Individual variability in concentrations of urinary sulindac sulfide.
    Brandli DW; Sarkissian E; Ng SC; Paulus HE
    Clin Pharmacol Ther; 1991 Dec; 50(6):650-5. PubMed ID: 1752108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversible acute decrease in renal function by NSAIDs in cirrhosis.
    Brater DC; Anderson SA; Brown-Cartwright D
    Am J Med Sci; 1987 Sep; 294(3):168-74. PubMed ID: 3661615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
    Yoshida T; Kameda H; Ichikawa Y; Tojo T; Homma M
    J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of renal sympathectomy, sodium depletion and prostaglandin synthetase inhibition on prostaglandin production and [3H]PGE2 binding characteristics in rat kidney.
    Eriksson LO; Larsson B; Kullendorff CM; Andersson KE
    Acta Physiol Scand; 1990 Apr; 138(4):451-61. PubMed ID: 2112821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered renal and platelet arachidonic acid metabolism in cirrhosis.
    Laffi G; La Villa G; Pinzani M; Ciabattoni G; Patrignani P; Mannelli M; Cominelli F; Gentilini P
    Gastroenterology; 1986 Feb; 90(2):274-82. PubMed ID: 3079716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin II-induced hypertension in the rat. Effects on the plasma concentration, renal excretion, and tissue release of prostaglandins.
    Diz DI; Baer PG; Nasjletti A
    J Clin Invest; 1983 Aug; 72(2):466-77. PubMed ID: 6575977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of sulindac on prostaglandin synthesis in human and in cultured rat renal and vascular smooth muscle cells.
    Sato M; Abe K; Takeuchi K; Yasujima M; Akiu N; Saito T; Yoshinaga K
    Tohoku J Exp Med; 1992 Jan; 166(1):185-200. PubMed ID: 1412444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of sulindac and naproxen in patients with chronic glomerular disease.
    Kamper AL; Strandgaard S; Christensen P; Svendsen UG
    Scand J Rheumatol Suppl; 1986; 62():26-31. PubMed ID: 3541165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
    Livio M; Benigni A; Zoja C; Begnis R; Morelli C; Rossini M; Garattini S; Remuzzi G
    J Pharmacol Exp Ther; 1989 Jan; 248(1):334-41. PubMed ID: 2492341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal hemodynamic effects of nabumetone, sulindac, and placebo in patients with osteoarthritis.
    Cangiano JL; Figueroa J; Palmer R
    Clin Ther; 1999 Mar; 21(3):503-12. PubMed ID: 10321419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of dexamethasone on in vivo prostanoid production in the rabbit.
    Náray-Fejes-Tóth A; Fejes-Tóth G; Fischer C; Frölich JC
    J Clin Invest; 1984 Jul; 74(1):120-3. PubMed ID: 6429194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.